Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy

The treatment of bone diseases (including osteoporosis, osteoarthritis, and bone cancer) often results in reduced efficiency and/or adverse reactions due to the fact that it is not specifically targeted to the site of action. The employment of a suitable carrier should increase drug location to the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Simona Sapino, Giulia Chindamo, Daniela Chirio, Maela Manzoli, Elena Peira, Chiara Riganti, Marina Gallarate
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/d8112b6d9e3342b1ba5f3fabff378314
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d8112b6d9e3342b1ba5f3fabff378314
record_format dspace
spelling oai:doaj.org-article:d8112b6d9e3342b1ba5f3fabff3783142021-11-25T18:31:24ZCalcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy10.3390/nano111129832079-4991https://doaj.org/article/d8112b6d9e3342b1ba5f3fabff3783142021-11-01T00:00:00Zhttps://www.mdpi.com/2079-4991/11/11/2983https://doaj.org/toc/2079-4991The treatment of bone diseases (including osteoporosis, osteoarthritis, and bone cancer) often results in reduced efficiency and/or adverse reactions due to the fact that it is not specifically targeted to the site of action. The employment of a suitable carrier should increase drug location to the site of bone disease. The purpose of this study is to prepare and characterize lipid nanoparticles (NPs) coated with calcium phosphate (CaP-NPs). A coating method, to date used only to obtain liposomes covered with CaP, is herein partially-modified to prepare CaP-coated lipid NPs. An extensive physico-chemical characterization was achieved by employing several techniques (DLS, SEM and TEM, and both combined with EDS, XRD, and FTIR) that confirmed the feasibility of the developed coating method. Preliminary uptake studies on human osteosarcoma cells (U-2OS) were performed by entrapping, as a lipid probe, Sudan Red III in NPs. The obtained data provided evidence that CaP-NPs showed higher cell accumulation than uncoated NPs. This result may have important implications for the development of drug loaded CaP-NPs to be tested in vitro with a view of planning future treatment of bone diseases, and indicate that CaP-NPs are potential vehicles for selective drug delivery to bone tissue.Simona SapinoGiulia ChindamoDaniela ChirioMaela ManzoliElena PeiraChiara RigantiMarina GallarateMDPI AGarticlelipid nanoparticlescalcium phosphate coatingbone diseaseshuman osteosarcoma cellscellular uptakeChemistryQD1-999ENNanomaterials, Vol 11, Iss 2983, p 2983 (2021)
institution DOAJ
collection DOAJ
language EN
topic lipid nanoparticles
calcium phosphate coating
bone diseases
human osteosarcoma cells
cellular uptake
Chemistry
QD1-999
spellingShingle lipid nanoparticles
calcium phosphate coating
bone diseases
human osteosarcoma cells
cellular uptake
Chemistry
QD1-999
Simona Sapino
Giulia Chindamo
Daniela Chirio
Maela Manzoli
Elena Peira
Chiara Riganti
Marina Gallarate
Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
description The treatment of bone diseases (including osteoporosis, osteoarthritis, and bone cancer) often results in reduced efficiency and/or adverse reactions due to the fact that it is not specifically targeted to the site of action. The employment of a suitable carrier should increase drug location to the site of bone disease. The purpose of this study is to prepare and characterize lipid nanoparticles (NPs) coated with calcium phosphate (CaP-NPs). A coating method, to date used only to obtain liposomes covered with CaP, is herein partially-modified to prepare CaP-coated lipid NPs. An extensive physico-chemical characterization was achieved by employing several techniques (DLS, SEM and TEM, and both combined with EDS, XRD, and FTIR) that confirmed the feasibility of the developed coating method. Preliminary uptake studies on human osteosarcoma cells (U-2OS) were performed by entrapping, as a lipid probe, Sudan Red III in NPs. The obtained data provided evidence that CaP-NPs showed higher cell accumulation than uncoated NPs. This result may have important implications for the development of drug loaded CaP-NPs to be tested in vitro with a view of planning future treatment of bone diseases, and indicate that CaP-NPs are potential vehicles for selective drug delivery to bone tissue.
format article
author Simona Sapino
Giulia Chindamo
Daniela Chirio
Maela Manzoli
Elena Peira
Chiara Riganti
Marina Gallarate
author_facet Simona Sapino
Giulia Chindamo
Daniela Chirio
Maela Manzoli
Elena Peira
Chiara Riganti
Marina Gallarate
author_sort Simona Sapino
title Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
title_short Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
title_full Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
title_fullStr Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
title_full_unstemmed Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
title_sort calcium phosphate-coated lipid nanoparticles as a potential tool in bone diseases therapy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d8112b6d9e3342b1ba5f3fabff378314
work_keys_str_mv AT simonasapino calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy
AT giuliachindamo calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy
AT danielachirio calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy
AT maelamanzoli calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy
AT elenapeira calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy
AT chiarariganti calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy
AT marinagallarate calciumphosphatecoatedlipidnanoparticlesasapotentialtoolinbonediseasestherapy
_version_ 1718411048405434368